80
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

The alliance with expanding blood volume and correcting anemia is an effective therapeutic measure for the adult anemia patients of acute cerebral infarction

, , &
Pages 429-434 | Received 10 Apr 2017, Accepted 11 Oct 2017, Published online: 30 Oct 2017

References

  • Mehndiratta P, Chapman Smith S, Worrall BB. Etiologic stroke subtypes: updated definition and efficient workup strategies. Curr Treat Opt Cardiovasc Med. 2015;17(1):357.
  • Abboud H, Labreuche J, Gongora-Riverra F, et al. Prevalence and determinants of subdiaphragmatic visceral infarction in patients with fatal stroke. Stroke. 2007;38(5):1442–1446.
  • Arboix A, Marti-Vilalta JL. New concepts in lacunar stroke etiology: the constellation of small-vessel arterial disease. Cerebrovasc Dis. 2004;17(Suppl 1):58–62.
  • Calvet D, Bernaudin F, Gueguen A, et al. First ischemic stroke in sickle-cell disease: are there any adult specificities? Stroke. 2015;46(8):2315–2317.
  • Caughey MC, Loehr LR, Key NS, et al. Sickle cell trait and incident ischemic stroke in the Atherosclerosis Risk in Communities study. Stroke. 2014;45(10):2863–2867.
  • Cowan LT, Alonso A, Pankow JS, et al. Hospitalized infection as a trigger for acute ischemic stroke: the Atherosclerosis Risk in Communities study. Stroke. 2016;47(6):1612–1617.
  • Quinn CT, Dowling MM. Anemia and ischemia: how low can you go? Blood. 2015;125(10):1516–1517.
  • Milionis H, Papavasileiou V, Eskandari A, et al. Anemia on admission predicts short- and long-term outcomes in patients with acute ischemic stroke. Int J Stroke. 2015;10(2):224–230.
  • Cancio MI, Helton KJ, Schreiber JE, et al. Silent cerebral infarcts in very young children with sickle cell anaemia are associated with a higher risk of stroke. Br J Haematol. 2015;171(1):120–129.
  • Soares D, Bullock R, Ali S. Moyamoya syndrome in sickle cell anaemia: a cause of recurrent stroke. BMJ Case Rep. 2014; 2014:bcr2014203727. doi:10.1136/bcr-2014-203727.
  • Petrova JJ, Manolov VE, Hadjidekova SP, et al. Is there a link between changes in levels of hepcidin and stroke? Clin Lab. 2015;61(12):1935–1939.
  • Fromm A, Haaland OA, Naess H, et al. Atherosclerosis in Trial of Org 10172 in Acute Stroke Treatment subtypes among young and middle-aged stroke patients: the Norwegian stroke in the Young Study. J Stroke Cerebrovasc Dis. 2016;25(4):825–830.
  • Chung JW, Park SH, Kim N, et al. Trial of ORG 10172 in Acute Stroke Treatment (TOAST) classification and vascular territory of ischemic stroke lesions diagnosed by diffusion-weighted imaging. J Am Heart Assoc. 2014;3(4):e001119. doi:10.1161/JAHA.114.001119.
  • Adams HP Jr., Davis PH, Leira EC, et al. Baseline NIH Stroke Scale score strongly predicts outcome after stroke: a report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology. 1999;53(1):126–131.
  • Cavusoglu E, Eng C, Chopra V, et al. Usefulness of the serum complement component C4 as a predictor of stroke in patients with known or suspected coronary artery disease referred for coronary angiography. Am J Cardiol. 2007;100(2):164–168.
  • Munshi A, Sharma V, Kaul S, et al. Estrogen receptor alpha genetic variants and the risk of stroke in a South Indian population from Andhra Pradesh. Clin Chim Acta. 2010;411(21–22):1817–1821.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.